nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—COMT—attention deficit hyperactivity disorder	0.849	1	CbGaD
Dobutamine—COMT—Enzymatic degradation of Dopamine by monoamine oxidase—MAOA—attention deficit hyperactivity disorder	0.0124	0.0984	CbGpPWpGaD
Dobutamine—COMT—Clearance of dopamine—SLC6A3—attention deficit hyperactivity disorder	0.0106	0.0843	CbGpPWpGaD
Dobutamine—COMT—Clearance of dopamine—MAOA—attention deficit hyperactivity disorder	0.00895	0.0712	CbGpPWpGaD
Dobutamine—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.00484	0.0385	CbGpPWpGaD
Dobutamine—ADRB1—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.00473	0.0376	CbGpPWpGaD
Dobutamine—ADRB2—Adrenoceptors—ADRA2C—attention deficit hyperactivity disorder	0.00463	0.0368	CbGpPWpGaD
Dobutamine—COMT—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00408	0.0325	CbGpPWpGaD
Dobutamine—COMT—Dopamine metabolism—MAOA—attention deficit hyperactivity disorder	0.00277	0.022	CbGpPWpGaD
Dobutamine—ADRB1—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.00249	0.0198	CbGpPWpGaD
Dobutamine—COMT—Biogenic Amine Synthesis—MAOA—attention deficit hyperactivity disorder	0.00247	0.0196	CbGpPWpGaD
Dobutamine—ADRB2—Adrenoceptors—ADRA2A—attention deficit hyperactivity disorder	0.00243	0.0193	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00167	0.0133	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.00164	0.013	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00164	0.013	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0016	0.0127	CbGpPWpGaD
Dobutamine—COMT—forebrain—attention deficit hyperactivity disorder	0.00147	0.0792	CbGeAlD
Dobutamine—Dopamine—DRD5—attention deficit hyperactivity disorder	0.00144	0.221	CrCbGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00141	0.0112	CbGpPWpGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00138	0.011	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00138	0.0109	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.00135	0.0107	CbGpPWpGaD
Dobutamine—CA5B—cardiovascular system—attention deficit hyperactivity disorder	0.00135	0.0727	CbGeAlD
Dobutamine—ADRB1—forebrain—attention deficit hyperactivity disorder	0.00124	0.0671	CbGeAlD
Dobutamine—COMT—cardiovascular system—attention deficit hyperactivity disorder	0.00124	0.0669	CbGeAlD
Dobutamine—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.00105	0.0567	CbGeAlD
Dobutamine—COMT—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00101	0.00803	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.000993	0.0079	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.000972	0.00772	CbGpPWpGaD
Dobutamine—COMT—midbrain—attention deficit hyperactivity disorder	0.000969	0.0523	CbGeAlD
Dobutamine—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.000955	0.00759	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.000934	0.00743	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000923	0.00734	CbGpPWpGaD
Dobutamine—CA2—forebrain—attention deficit hyperactivity disorder	0.000912	0.0492	CbGeAlD
Dobutamine—Dopamine—COMT—attention deficit hyperactivity disorder	0.000907	0.14	CrCbGaD
Dobutamine—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.000903	0.00718	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.000894	0.00711	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.000879	0.00699	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.000875	0.00696	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000868	0.0069	CbGpPWpGaD
Dobutamine—CA5B—nervous system—attention deficit hyperactivity disorder	0.000865	0.0467	CbGeAlD
Dobutamine—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00086	0.00684	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.000849	0.00675	CbGpPWpGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000835	0.00664	CbGpPWpGaD
Dobutamine—CA5B—central nervous system—attention deficit hyperactivity disorder	0.000833	0.0449	CbGeAlD
Dobutamine—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.000817	0.00649	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000809	0.00643	CbGpPWpGaD
Dobutamine—COMT—nervous system—attention deficit hyperactivity disorder	0.000797	0.043	CbGeAlD
Dobutamine—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.000791	0.00629	CbGpPWpGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000776	0.00617	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000774	0.00615	CbGpPWpGaD
Dobutamine—CA2—cardiovascular system—attention deficit hyperactivity disorder	0.000771	0.0416	CbGeAlD
Dobutamine—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00077	0.00613	CbGpPWpGaD
Dobutamine—COMT—central nervous system—attention deficit hyperactivity disorder	0.000767	0.0414	CbGeAlD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.000759	0.00604	CbGpPWpGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000752	0.00598	CbGpPWpGaD
Dobutamine—COMT—cerebellum—attention deficit hyperactivity disorder	0.00075	0.0404	CbGeAlD
Dobutamine—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000739	0.00587	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.000735	0.00585	CbGpPWpGaD
Dobutamine—Dopamine—DRD4—attention deficit hyperactivity disorder	0.000735	0.113	CrCbGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00073	0.0058	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.000723	0.00575	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.000714	0.00568	CbGpPWpGaD
Dobutamine—Dopamine—MAOA—attention deficit hyperactivity disorder	0.000684	0.105	CrCbGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00068	0.0054	CbGpPWpGaD
Dobutamine—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000675	0.0364	CbGeAlD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.000665	0.00529	CbGpPWpGaD
Dobutamine—CA5B—brain—attention deficit hyperactivity disorder	0.000661	0.0357	CbGeAlD
Dobutamine—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.00065	0.035	CbGeAlD
Dobutamine—Dopamine—DRD3—attention deficit hyperactivity disorder	0.000634	0.0977	CrCbGaD
Dobutamine—Dopamine—DRD1—attention deficit hyperactivity disorder	0.000622	0.0959	CrCbGaD
Dobutamine—COMT—brain—attention deficit hyperactivity disorder	0.000609	0.0328	CbGeAlD
Dobutamine—CA2—midbrain—attention deficit hyperactivity disorder	0.000602	0.0325	CbGeAlD
Dobutamine—Dopamine—SLC6A3—attention deficit hyperactivity disorder	0.00059	0.0909	CrCbGaD
Dobutamine—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.000569	0.00452	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000566	0.0045	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.000556	0.00442	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.000554	0.00441	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000517	0.00411	CbGpPWpGaD
Dobutamine—ADRB1—brain—attention deficit hyperactivity disorder	0.000516	0.0278	CbGeAlD
Dobutamine—CA2—nervous system—attention deficit hyperactivity disorder	0.000495	0.0267	CbGeAlD
Dobutamine—CA2—central nervous system—attention deficit hyperactivity disorder	0.000477	0.0257	CbGeAlD
Dobutamine—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000476	0.00379	CbGpPWpGaD
Dobutamine—CA2—cerebellum—attention deficit hyperactivity disorder	0.000466	0.0251	CbGeAlD
Dobutamine—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.000466	0.0037	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000444	0.00353	CbGpPWpGaD
Dobutamine—Dopamine—SLC6A4—attention deficit hyperactivity disorder	0.000441	0.068	CrCbGaD
Dobutamine—Dopamine—DRD2—attention deficit hyperactivity disorder	0.000439	0.0676	CrCbGaD
Dobutamine—COMT—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000413	0.00329	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000396	0.00315	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.000389	0.00309	CbGpPWpGaD
Dobutamine—CA2—brain—attention deficit hyperactivity disorder	0.000378	0.0204	CbGeAlD
Dobutamine—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.000377	0.003	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000368	0.00293	CbGpPWpGaD
Dobutamine—COMT—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000351	0.00279	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000341	0.00271	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000323	0.00257	CbGpPWpGaD
Dobutamine—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00032	0.00255	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000317	0.00252	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000316	0.00252	CbGpPWpGaD
Dobutamine—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.000316	0.00251	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.000316	0.00251	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000314	0.0025	CbGpPWpGaD
Dobutamine—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.000313	0.00249	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000311	0.00247	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.000309	0.00246	CbGpPWpGaD
Dobutamine—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.000309	0.00246	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.000307	0.00244	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000282	0.00224	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000277	0.0022	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000271	0.00215	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.000271	0.00215	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.000265	0.00211	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000261	0.00207	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.000246	0.00196	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000243	0.00194	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000238	0.00189	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000219	0.00174	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.000215	0.00171	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000211	0.00168	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000206	0.00164	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.000206	0.00164	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.000202	0.00161	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000192	0.00152	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000188	0.00149	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000187	0.00149	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000184	0.00146	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00018	0.00143	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00018	0.00143	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000178	0.00142	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000178	0.00141	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000177	0.00141	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000174	0.00139	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000174	0.00138	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000173	0.00137	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000172	0.00137	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00017	0.00135	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000169	0.00134	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000168	0.00134	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000168	0.00134	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000168	0.00133	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000166	0.00132	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000165	0.00131	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000165	0.00131	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000164	0.00131	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000164	0.0013	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000161	0.00128	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000161	0.00128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000158	0.00125	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000156	0.00124	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000154	0.00122	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000153	0.00121	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000153	0.00121	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000149	0.00119	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000148	0.00118	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.00116	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000145	0.00115	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000144	0.00115	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000144	0.00114	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000144	0.00114	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000143	0.00114	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000142	0.00113	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00014	0.00112	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00014	0.00111	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000137	0.00109	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000134	0.00107	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000134	0.00106	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000131	0.00104	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000128	0.00102	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000125	0.000994	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000122	0.000973	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000119	0.000947	CbGpPWpGaD
Dobutamine—CA2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000119	0.000946	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000119	0.000946	CbGpPWpGaD
Dobutamine—CA2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000117	0.000931	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000117	0.000927	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000116	0.000926	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000116	0.000924	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000114	0.000907	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000114	0.000904	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000113	0.000895	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.00088	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00011	0.000876	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000109	0.000869	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000109	0.000869	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—COMT—attention deficit hyperactivity disorder	0.000109	0.000867	CbGpPWpGaD
Dobutamine—CA2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000109	0.000865	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000108	0.000861	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000108	0.000861	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000108	0.00086	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000107	0.00085	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000107	0.00085	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000106	0.000842	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000106	0.000841	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000104	0.000824	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000102	0.00081	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—COMT—attention deficit hyperactivity disorder	0.000102	0.000809	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000101	0.000804	CbGpPWpGaD
Dobutamine—COMT—Metabolism—TPH2—attention deficit hyperactivity disorder	9.97e-05	0.000793	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.97e-05	0.000793	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.96e-05	0.000792	CbGpPWpGaD
Dobutamine—COMT—Metabolism—DPYD—attention deficit hyperactivity disorder	9.81e-05	0.00078	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.52e-05	0.000757	CbGpPWpGaD
Dobutamine—CA2—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.51e-05	0.000756	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.37e-05	0.000745	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	9.32e-05	0.000741	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	9.16e-05	0.000728	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.12e-05	0.000725	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.06e-05	0.00072	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	8.08e-05	0.000643	CbGpPWpGaD
Dobutamine—COMT—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.97e-05	0.000634	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.91e-05	0.000629	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.59e-05	0.000603	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.43e-05	0.000591	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.34e-05	0.000584	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	7.27e-05	0.000578	CbGpPWpGaD
Dobutamine—CA2—Metabolism—COMT—attention deficit hyperactivity disorder	7.21e-05	0.000573	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	7.18e-05	0.000571	CbGpPWpGaD
Dobutamine—CA2—Metabolism—MAOA—attention deficit hyperactivity disorder	7.16e-05	0.000569	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	7.13e-05	0.000567	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	7.07e-05	0.000562	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.98e-05	0.000555	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.91e-05	0.00055	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.57e-05	0.000522	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.43e-05	0.000511	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.42e-05	0.00051	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.39e-05	0.000508	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.36e-05	0.000506	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.28e-05	0.000499	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.26e-05	0.000497	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.25e-05	0.000497	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.25e-05	0.000497	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.22e-05	0.000495	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.18e-05	0.000491	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.14e-05	0.000488	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.12e-05	0.000487	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.12e-05	0.000486	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.04e-05	0.00048	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6e-05	0.000477	CbGpPWpGaD
Dobutamine—COMT—Metabolism—MAOA—attention deficit hyperactivity disorder	6e-05	0.000477	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.97e-05	0.000474	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.84e-05	0.000464	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.78e-05	0.000459	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.75e-05	0.000458	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.68e-05	0.000452	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.65e-05	0.000449	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.63e-05	0.000448	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.61e-05	0.000446	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.56e-05	0.000442	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.49e-05	0.000436	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.23e-05	0.000415	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.11e-05	0.000406	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—EP300—attention deficit hyperactivity disorder	4.68e-05	0.000372	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—EP300—attention deficit hyperactivity disorder	4.37e-05	0.000347	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.34e-05	0.000345	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.24e-05	0.000337	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.03e-05	0.00032	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.94e-05	0.000313	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.79e-05	0.000301	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.71e-05	0.000295	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.66e-05	0.000291	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.58e-05	0.000285	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.52e-05	0.00028	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.45e-05	0.000274	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.41e-05	0.000271	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.36e-05	0.000267	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.34e-05	0.000265	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.31e-05	0.000263	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.28e-05	0.000261	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.24e-05	0.000258	CbGpPWpGaD
Dobutamine—CA2—Metabolism—EP300—attention deficit hyperactivity disorder	3.09e-05	0.000246	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.09e-05	0.000245	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.02e-05	0.00024	CbGpPWpGaD
Dobutamine—COMT—Metabolism—EP300—attention deficit hyperactivity disorder	2.59e-05	0.000206	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.16e-05	0.000172	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.11e-05	0.000168	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.15e-05	9.11e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.12e-05	8.91e-05	CbGpPWpGaD
